PMID- 34277536
OWN - NLM
STAT- MEDLINE
DCOM- 20210721
LR  - 20240402
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 9
DP  - 2021
TI  - Preliminary Assessment of Chinese Strategy in Controlling Reemergent Local 
      Outbreak of COVID-19.
PG  - 650672
LID - 10.3389/fpubh.2021.650672 [doi]
LID - 650672
AB  - Reemergent local outbreaks of coronavirus disease 2019 (COVID-19) have occurred 
      in China, yet few Chinese response strategies and its evaluation have been 
      reported. This study presents a preliminary assessment of Chinese strategy in 
      controlling reemergent local outbreaks of COVID-19. Time course of accumulative 
      and daily new cases and time-varying reproductive numbers (Rt) of outbreak areas 
      were presented. The asymptomatic rate, days required to control the outbreaks, 
      seeding time (ST), and doubling time (DT) of areas with over 96 reemergent cases 
      were calculated. National and local year-on-year growth rates of gross domestic 
      product (GDP) were presented. Accumulative numbers of 30, 8, 11, 430, 15, 139, 
      1,067, 382, 42, and 94 confirmed reemergent COVID-19 cases were diagnosed in 
      Hulun Buir, Shanghai, Tianjin, Kashgar, Qingdao, Dalian, Urumchi, Beijing, Jilin, 
      and Harbin, respectively. Among them, maximum rate of asymptomatic infections was 
      81.9%. Time required to control the local outbreaks in the areas given above 
      varied from 29 to 51 days. After activation of outbreak responses, the late-stage 
      DTs of Kashgar, Urumchi, Beijing, and Dalian were apparently lengthened compared 
      to the early-stage DTs. Although the year-on-year GDP growth rate of Urumchi was 
      slightly affected, the GDP growth rate of Dalian, Beijing, Jilin, and Harbin kept 
      rising during the reemergence. Moreover, the year-on-year GDP growth rate of 
      Mainland China turned positive regardless of the reemergent local outbreaks. In 
      general, the Chinese strategy to maintain the status of no or minimal 
      transmission was effective in balancing the control of COVID-19 reemergent local 
      outbreak and the recovery of economy.
CI  - Copyright (c) 2021 Wang, Jin, Jin, Lu, Yu, Li and Zhang.
FAU - Wang, Zhouhan
AU  - Wang Z
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
FAU - Jin, Yanqi
AU  - Jin Y
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
FAU - Jin, Xi
AU  - Jin X
AD  - Department of Gastroenterology, The First Affiliated Hospital, College of 
      Medicine, Zhejiang University, Hangzhou, China.
FAU - Lu, Yingfeng
AU  - Lu Y
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
FAU - Yu, Xiaopeng
AU  - Yu X
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
FAU - Li, Lanjuan
AU  - Li L
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
FAU - Zhang, Yimin
AU  - Zhang Y
AD  - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 
      Department of Infectious Diseases, National Clinical Research Center for 
      Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment 
      of Infectious Diseases, The First Affiliated Hospital, College of Medicine, 
      Zhejiang University, Hangzhou, China.
AD  - Department of Infectious Diseases, The First Affiliated Hospital, College of 
      Medicine, Zhejiang University, Hangzhou, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210702
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
SB  - IM
MH  - Beijing
MH  - *COVID-19
MH  - China/epidemiology
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - SARS-CoV-2
PMC - PMC8283522
OTO - NOTNLM
OT  - COVID-19
OT  - China
OT  - GDP
OT  - SARS-CoV-2
OT  - asymptomatic infection
OT  - reemergent local outbreak
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2021/07/20 06:00
MHDA- 2021/07/22 06:00
PMCR- 2021/07/02
CRDT- 2021/07/19 06:00
PHST- 2021/01/07 00:00 [received]
PHST- 2021/05/31 00:00 [accepted]
PHST- 2021/07/19 06:00 [entrez]
PHST- 2021/07/20 06:00 [pubmed]
PHST- 2021/07/22 06:00 [medline]
PHST- 2021/07/02 00:00 [pmc-release]
AID - 10.3389/fpubh.2021.650672 [doi]
PST - epublish
SO  - Front Public Health. 2021 Jul 2;9:650672. doi: 10.3389/fpubh.2021.650672. 
      eCollection 2021.